Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder
Somkuwar, Sucharita S.
Kantak, Kathleen M.
Dwoskin, Linda P.
MetadataShow full item record
CitationSucharita S. Somkuwar, Kathleen M. Kantak, Linda P. Dwoskin. 2015. "Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.." J Neurosci Methods, v. 252, pp. 55 - 63.
Attention deficit hyperactivity disorder (ADHD) is associated with hypofunctional medial prefrontal cortex (mPFC) and orbitofrontal cortex (OFC). Methylphenidate (MPH) remediates ADHD, in part, by inhibiting the norepinephrine transporter (NET). MPH also reduces ADHD-like symptoms in spontaneously hypertensive rats (SHRs), a model of ADHD. However, effects of chronic MPH treatment on NET function in mPFC and OFC in SHR have not been reported. In the current study, long-term effects of repeated treatment with a therapeutically relevant oral dose of MPH during adolescence on NET function in subregions of mPFC (cingulate gyrus, prelimbic cortex and infralimbic cortex) and in the OFC of adult SHR, Wistar-Kyoto (WKY, inbred control) and Wistar (WIS, outbred control) rats were determined using in vivo voltammetry. Following local ejection of norepinephrine (NE), uptake rate was determined as peak amplitude (Amax)× first-order rate constant (k-1). In mPFC subregions, no strain or treatment effects were found in NE uptake rate. In OFC, NE uptake rate in vehicle-treated adult SHR was greater than in adult WKY and WIS administered vehicle. MPH treatment during adolescence normalized NE uptake rate in OFC in SHR. Thus, the current study implicates increased NET function in OFC as an underlying mechanism for reduced noradrenergic transmission in OFC, and consequently, the behavioral deficits associated with ADHD. MPH treatment during adolescence normalized NET function in OFC in adulthood, suggesting that the therapeutic action of MPH persists long after treatment cessation and may contribute to lasting reductions in deficits associated with ADHD.
RightsAttribution-NonCommercial-NoDerivatives 4.0 International
Showing items related by title, author, creator and subject.
Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder Baskin, Britahny M.; Dwoskin, Linda P.; Kantak, Kathleen M. (Elsevier, 2015-04)Past research with the spontaneously hypertensive rat (SHR) model of attention deficit/hyperactivity disorder showed that adolescent methylphenidate treatment enhanced cocaine abuse risk in SHR during adulthood. The ...
Exposure to Polyfluoroalkyl Chemicals and Attention Deficit/Hyperactivity Disorder in U.S. Children 12-15 Years of Age Hoffman, Kate; Webster, Thomas F.; Weisskopf, Marc G.; Weinberg, Janice; Vieira, Verónica M. (National Institute of Environmental Health Sciences, 2010-12)BACKGROUND. Polyfluoroalkyl chemicals (PFCs) have been widely used in consumer products. Exposures in the United States and in world populations are widespread. PFC exposures have been linked to various health impacts, and ...
Blum, Kenneth; Chen, Amanda Lih-Chuan; Braverman, Eric R.; Comings, David E; Chen, Thomas J. H.; Arcuri, Vanessa; Blum, Seth H.; Downs, Bernard W.; Waite, Roger L.; Notaro, Alison; Lubar, Joel; Williams, Lonna; Prihoda, Thomas J.; Palomo, Tomas; Oscar-Berman, Marlene (Dove Medical Press, 2008)Molecular genetic studies have identified several genes that may mediate susceptibility to attention deficit hyperactivity disorder (ADHD). A consensus of the literature suggests that when there is a dysfunction in the ...